Clinical trial
Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of…
NCT00136981 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00136981 |
|---|---|
| Title | Carotid B-Mode Ultrasound Study to Compare Anti-Atherosclerotic Effect of Torcetrpib/Atorvastatin to Atorvastatin Alone. |
| Official title | Phase 3 Multi-Center, Double-Blind, Randomized, Parallel Group, Carotid B-Mode Ultrasound Evaluation of the Anti-Atherosclerotic Efficacy, Safety and Tolerability of Fixed Combination CP-529,414/Atorvastatin, Administered Orally, Once Daily (QD) for 24 Months, Compared With Maximally Tolerated… |
| Acronym | RADIANCE 1 |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia, Familial, Hyperlipidemia |
| Intervention type | Drug |
| Interventions | torcetrapib/atorvastatin, atorvastatin |
| Enrollment | 800 |
| Start date | Dec 1, 2003 |
| Completion | Nov 1, 2006 |
| First posted | Aug 29, 2005 |
| Last update posted | Apr 22, 2015 |
| Countries | Canada, Czechia, Finland, France, Italy, Netherlands, South Africa, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: